Related content

In Mexican Mestizos the HCP5 rs2395029 SNP may be a genetic marker for screening abacavir hypersensitivity

By Sanchez-Giron Francisco   Carnevale Alessandra  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 251-252

Future Medicine

Access to resources Recommend Favorite

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

By Hughes Arlene R   Mosteller Michael   Bansal Aruna T   Davies Kirstie   Haneline Stephen A   Lai Eric H   Nangle Keith   Scott Trevor   Spreen William R   Warren Liling L   Roses Allen D    

Pharmacogenomics, Vol. 5, Iss. 2, 2004-03 ,pp. : 203-211

Future Medicine

Access to resources Recommend Favorite

Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR

By Dello Russo Cinzia   Lisi Lucia   Lofaro Alessia   Di Giambenedetto Simona   Federico Bruno   Madeddu Giordano   Salerno Marianna   Mura Maria Stella   Pirazzoli Antonella   de Luca Andrea   Cauda Roberto   Navarra Pierluigi  

Pharmacogenomics, Vol. 12, Iss. 4, 2011-04 ,pp. : 567-576

Future Medicine

Access to resources Recommend Favorite

Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population

By Badulli Carla   Sestini Roberta   Sbarsi Ilaria   Baroncelli Marta   Pizzochero Cinzia   Martinetti Miryam   Porfirio Berardino  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 247-249

Future Medicine

Access to resources Recommend Favorite

HLA-B*5701 screening should become component of HIV care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 616, 2010-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite